DK0544826T3 - Overlegne trombomodulinanaloger til farmaceutisk anvendelse - Google Patents

Overlegne trombomodulinanaloger til farmaceutisk anvendelse

Info

Publication number
DK0544826T3
DK0544826T3 DK91918117T DK91918117T DK0544826T3 DK 0544826 T3 DK0544826 T3 DK 0544826T3 DK 91918117 T DK91918117 T DK 91918117T DK 91918117 T DK91918117 T DK 91918117T DK 0544826 T3 DK0544826 T3 DK 0544826T3
Authority
DK
Denmark
Prior art keywords
thrombin
superior
pharmaceutical use
analogs
methods
Prior art date
Application number
DK91918117T
Other languages
Danish (da)
English (en)
Inventor
Michael John Morser
Charles B Glaser
David Richard Light
Original Assignee
Paion Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paion Gmbh filed Critical Paion Gmbh
Application granted granted Critical
Publication of DK0544826T3 publication Critical patent/DK0544826T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK91918117T 1990-08-15 1991-08-15 Overlegne trombomodulinanaloger til farmaceutisk anvendelse DK0544826T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56845690A 1990-08-15 1990-08-15
PCT/US1991/005806 WO1992003149A1 (en) 1990-08-15 1991-08-15 Superior thrombomodulin analogs for pharmaceutical use

Publications (1)

Publication Number Publication Date
DK0544826T3 true DK0544826T3 (da) 2002-04-22

Family

ID=24271371

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91918117T DK0544826T3 (da) 1990-08-15 1991-08-15 Overlegne trombomodulinanaloger til farmaceutisk anvendelse

Country Status (8)

Country Link
EP (1) EP0544826B1 (de)
AT (1) ATE211390T1 (de)
AU (2) AU8723391A (de)
CA (2) CA2087271C (de)
DE (1) DE69132889T2 (de)
DK (1) DK0544826T3 (de)
ES (1) ES2170747T3 (de)
WO (1) WO1992003149A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
FR2689640B1 (fr) * 1992-04-06 1997-08-08 Bio Merieux Procede pour la determination d'une activite proteine c et/ou proteine s dans un echantillon plasmatique.
US6500646B1 (en) 1996-12-27 2002-12-31 Mochida Pharmaceutical Co., Ltd. Cell membrane-directed drugs
DE19749197A1 (de) * 1997-11-07 1999-05-12 Dade Behring Marburg Gmbh Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
CA2502539A1 (en) * 2002-10-17 2004-04-29 Pharming Intellectual Property B.V. Protein modification
US7553930B2 (en) 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
BRPI0720158A2 (pt) 2006-10-06 2014-05-20 Asahi Kasei Pharma Corp Agentes para terapia e/ou melhora de coagulação intravascular disseminada, para reduzir a probabilidade de morte em pacientes sofrendo da mesma, métodos para selecionar pacientes, e, para tratar e/ou melhorar coagulação intravascular disseminada
TW201431872A (zh) 2007-03-23 2014-08-16 Asahi Kasei Pharma Corp 高純度可溶性凝血酶調節素之製造方法
EP2120049A1 (de) 2008-05-14 2009-11-18 PAION Deutschland GmbH Lösliches Thrombomodulin als Biomarker bei Therapien mit Gerinnungshemmern
AU2009347614A1 (en) 2009-06-12 2012-01-19 Paion Deutschland Gmbh Treatment of coagulopathy with hyperfibrinolysis
AU2011246021B2 (en) 2010-04-30 2014-03-13 Asahi Kasei Pharma Corporation High-purity soluble thrombomodulin and method for producing same
CN103037893A (zh) 2010-06-14 2013-04-10 帕昂德国有限公司 具有纤溶亢进的凝血病的治疗
US9592275B2 (en) 2011-11-15 2017-03-14 Asahi Kasei Pharma Corporation Medicament for therapeutic treatment and/or improvement of sepsis
CA3116686A1 (en) 2018-10-22 2020-04-30 Asahi Kasei Pharma Corporation Medicament for therapeutic treatment and/or improvement of sepsis accompanied by coagulopathy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912207A (en) * 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof
DK299087D0 (da) * 1987-06-12 1987-06-12 Novo Industri As Proteins and derivatives thereof
AU646633B2 (en) * 1989-02-17 1994-03-03 Codon Soluble analogs of thrombomodulin
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs

Also Published As

Publication number Publication date
WO1992003149A1 (en) 1992-03-05
EP0544826B1 (de) 2002-01-02
ES2170747T3 (es) 2002-08-16
DE69132889T2 (de) 2002-08-29
AU692988B2 (en) 1998-06-18
CA2087271A1 (en) 1992-02-16
DE69132889D1 (de) 2002-02-07
CA2648350A1 (en) 1992-03-05
EP0544826A1 (de) 1993-06-09
ATE211390T1 (de) 2002-01-15
EP0544826A4 (de) 1994-04-27
CA2087271C (en) 2009-03-24
AU4554396A (en) 1996-04-26
AU8723391A (en) 1992-03-17

Similar Documents

Publication Publication Date Title
DK0544826T3 (da) Overlegne trombomodulinanaloger til farmaceutisk anvendelse
RU95115239A (ru) Аналог эритропоэтина
PT80631B (de) Verfahren zur herstellung von thrombin-inhibitoren
ATE133681T1 (de) Mykobakterielle rekombinanten und peptide
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
DE3684680D1 (de) Peptidplasminogenaktivatoren.
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
YU8997A (sh) Prečišćen protein koji ima serinsku proteaznu inhibitorsku aktivnost i farmaceutski preparat koji ga sadrži
ATE264913T1 (de) Protease-resistente analoge des thrombomodulin
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
NZ503235A (en) Amino-terminally truncated RANTES as chemokine antagonists
LTIP1753A (en) Dna sequences coding for proteins, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
KR880701073A (ko) 제조합 dna 기법에 의해 생성된 민악티빈
NL960017I1 (nl) Expressie van Factor VIII-activiteit in zoogdiercellen.
Glaser et al. Superior thrombomodulin analogs for pharmaceutical use